(Aliso Viejo, CA) November 13, 2018: Researchers from Ambry Genetics (Ambry), a leading clinical genetics testing lab, will present new scientific evidence on gene-disease relationships and how it supports medical management decisions at the National Society of Genetic Counselors (NSGC) Annual Meeting to be held in Atlanta, November 14-17.   Ambry has been selected by…

The AmbryShare project produced innovative research that may identify more at-risk women (Aliso Viejo) August 16, 2018 – Ambry Genetics Corporation (“Ambry”), a leader in high quality genetic testing, announced their research was published today in JAMA Oncology, identifying new and confirming known hereditary breast and ovarian cancer candidate genes in the largest exome study…

Ambry’s polygenic risk score (PRS) can provide clinicians with individualized breast cancer risk estimates (Aliso Viejo) June 3, 2018 – Ambry Genetics Corporation (“Ambry”), providers of high quality genetic testing, in collaboration with the Mayo Clinic and NorthShore University HealthSystem, announced today they are presenting important new data at the American Society of Clinical Oncology,…

An individual’s genetic make-up may influence personalized disease management (Aliso Viejo, CA; San Antonio, TX) December 5th, 2017: Ambry Genetics Corporation (Ambry), a leading clinical genetics-testing lab, is presenting data this week at San Antonio Breast Cancer Symposium (SABCS) to help the medical community further understand the genetic mutations behind hereditary breast cancer, which accounts…

The power of dedicated research, and discovery of new gene mutation variants helps develop much-needed treatments Aliso Viejo, CA (November 28, 2017): Ambry Genetics Corporation (Ambry), a leading clinical genetics-testing lab, recently published a paper concerning mutations in the FDXR gene, detailing how a team of researchers completed an entire diagnostic journey – from novel…

Aliso Viejo, CA (October 17, 2017): Ambry Genetics (Ambry), a leading clinical genetics-testing lab, announced today that they would be collaborating with PWNHealth to offer telemedicine genetic counseling as part of Ambry’s commitment to improve access to patient care. Due to the rapid growth of genetic testing, the need for telemedicine genetic counseling services is…

(October 16, 2017) Aliso Viejo, CA and Orlando, FL: Ambry Genetics Corporation (Ambry), a leading genetic testing lab, will be participating at the American Society of Human Genetics Annual Meeting (ASHG). Ambry’s 16 posters and 6 oral presentations cover the entire spectrum of research including many of the challenges currently facing the genetics community. One…

Collaboration to Increase the Diagnostic Power of Genetic Testing   ALISO VIEJO, Calif.–(BUSINESS WIRE)–Today, Ambry Genetics Corporation (“Ambry Genetics”) announces integration between their secure AmbryPort 2.0 (AP2) clinician ordering platform and FDNA’s Face2Gene® suite of applications. This integration is expected to dramatically increase and transform the diagnostic power of genetic testing in rare diseases. Driven to give clinicians the…

Aliso Viejo, CA and Columbus, OH. September 12, 2017: At this year’s National Society of Genetic Counselors (NSGC) Annual Meeting, Ambry Genetics (Ambry), a leader in advanced genetic testing, will be presenting ground-breaking research to the attending clinicians. Each year at NSGC, Ambry showcases science-advancing research and presentations that will change the genetic testing industry,…